Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion

被引:163
|
作者
Kim, Steven C. [1 ]
Mathews, David V. [1 ]
Breeden, Cynthia P. [1 ]
Higginbotham, Laura B. [1 ]
Ladowski, Joseph [2 ]
Martens, Gregory [2 ]
Stephenson, Allison [1 ]
Farris, Alton B. [1 ]
Strobert, Elizabeth A. [3 ]
Jenkins, Joe [3 ]
Walters, Eric M. [2 ]
Larsen, Christian P. [1 ,3 ]
Tector, Matthew [4 ]
Tector, Alfred J. [4 ]
Adams, Andrew B. [1 ,3 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Emory Transplant Ctr, Atlanta, GA 30322 USA
[2] Univ Missouri, Natl Swine Resource & Res Ctr, Columbia, MO USA
[3] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA
[4] Univ Alabama Birmingham, Sch Med, Comprehens Transplant Inst, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
animal models; nonhuman primate; basic (laboratory) research; science; costimulation; immunosuppressant - fusion proteins and monoclonal antibodies; costimulation molecule specific; immunosuppression; immune modulation; kidney transplantation; nephrology; translational research; xenoantibody; xenoantigen; xenotransplantation; COMPLEMENT REGULATORY PROTEINS; ANTI-CD40 LIGAND ANTIBODY; COSTIMULATION BLOCKADE; GRAFT-REJECTION; ORGAN; TRANSPLANTATION; KNOCKOUT; BABOON; XENOTRANSPLANTATION; SPECIFICITY;
D O I
10.1111/ajt.15329
中图分类号
R61 [外科手术学];
学科分类号
摘要
The shortage of available organs remains the greatest barrier to expanding access to transplant. Despite advances in genetic editing and immunosuppression, survival in experimental models of kidney xenotransplant has generally been limited to <100 days. We found that pretransplant selection of recipients with low titers of anti-pig antibodies significantly improved survival in a pig-to-rhesus macaque kidney transplant model (6 days vs median survival time 235 days). Immunosuppression included transient pan-T cell depletion and an anti-CD154-based maintenance regimen. Selective depletion of CD4(+) T cells but not CD8(+) T cells resulted in long-term survival (median survival time >400 days vs 6 days). These studies suggested that CD4(+) T cells may have a more prominent role in xenograft rejection compared with CD8(+) T cells. Although animals that received selective depletion of CD8(+) T cells showed signs of early cellular rejection (marked CD4(+) infiltrates), animals receiving selective CD4(+) depletion exhibited normal biopsy results until late, when signs of chronic antibody rejection were present. In vitro study results suggested that rhesus CD4(+) T cells required the presence of SLA class II to mount an effective proliferative response. The combination of low pretransplant anti-pig antibody and CD4 depletion resulted in consistent, long-term xenograft survival.
引用
收藏
页码:2174 / 2185
页数:12
相关论文
共 50 条
  • [41] Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time
    Zhou, Mi
    Bracci, Paige M.
    McCoy, Lucie S.
    Hsuang, George
    Wiemels, Joseph L.
    Rice, Terri
    Zheng, Shichun
    Kelsey, Karl T.
    Wrensch, Margaret R.
    Wiencke, John K.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (04) : 826 - 836
  • [42] Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
    Cappell, Kathryn M.
    Sherry, Richard M.
    Yang, James C.
    Goff, Stephanie L.
    Vanasse, Danielle A.
    McIntyre, Lori
    Rosenberg, Steven A.
    Kochenderfer, James N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3805 - +
  • [43] Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia
    Whittington, Melanie D.
    McQueen, R. Brett
    Ollendorf, Daniel A.
    Kumar, Varun M.
    Chapman, Richard H.
    Tice, Jeffrey A.
    Pearson, Steven D.
    Campbell, Jonathan D.
    JAMA PEDIATRICS, 2018, 172 (12) : 1161 - 1168
  • [44] Long-term survival of xenografted neonatal cardiomyocytes by adenovirus-mediated CTLA4-Ig expression and CD40 blockade
    Li, TS
    Ito, H
    Kajiwara, K
    Hamano, K
    CIRCULATION, 2003, 108 (14) : 1760 - 1765
  • [45] Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin's Lymphoma: Correlation with Long-Term Survival
    Tarella, Corrado
    Gueli, Angela
    Delaini, Federica
    Rossi, Andrea
    Barbui, Anna Maria
    Gritti, Giuseppe
    Boschini, Cristina
    Caracciolo, Daniele
    Bruna, Riccardo
    Ruella, Marco
    Gottardi, Daniela
    Passera, Roberto
    Rambaldi, Alessandro
    PLOS ONE, 2014, 9 (09):
  • [46] Long-Term Follow-Up of an Intensified Myeloablative Conditioning Regimen with In Vivo T Cell Depletion Followed by Allografting in Patients with Advanced Multiple Myeloma
    Kroeger, Nicolaus
    Einsele, Hermann
    Derigs, Guenter
    Wandt, Hannes
    Kruell, Andreas
    Zander, Axel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 861 - 864
  • [47] Genetically targeting the BATF family transcription factors BATF and BATF3 in the mouse abrogates effector T cell activities and enables long-term heart allograft survival
    Wang, Yixuan
    Xiao, Xiang
    Kong, Gangcheng
    Wen, Mou
    Wang, Guangchuan
    Ghobrial, Rafik M.
    Dong, Nianguo
    Chen, Wenhao
    Li, Xian C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (02) : 414 - 426
  • [48] CD28 LIGANDS CD80 (B7-1) AND CD86 (B7-2) INDUCE LONG-TERM AUTOCRINE GROWTH OF CD4(+) T-CELLS AND INDUCE SIMILAR PATTERNS OF CYTOKINE SECRETION IN-VITRO
    LEVINE, BL
    UEDA, Y
    CRAIGHEAD, N
    HUANG, ML
    JUNE, CH
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (06) : 891 - 904
  • [49] Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in α1,3-galactosyltransferase knockout (GT-Ko) mice
    Chong, ASF
    Ma, LL
    Yin, DP
    Shen, JK
    Blinder, L
    Xu, XL
    Williams, JW
    Byrne, G
    Diamond, LE
    Logan, JS
    XENOTRANSPLANTATION, 2000, 7 (04) : 275 - 283
  • [50] Anti-CD40 Monoclonal Antibody Synergizes with CTLA4-Ig in Promoting Long-Term Graft Survival in Murine Models of Transplantation
    Gilson, Christopher R.
    Milas, Zvonimir
    Gangappa, Shivaprakash
    Hollenbaugh, Diane
    Pearson, Thomas C.
    Ford, Mandy L.
    Larsen, Christian P.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (03) : 1625 - 1635